a chart with actual prices is here:
page 15
see here for an interesting survey on mortality bonds :
Milliman used an actuarial approach , while RMS used
an epidemiological approach , leading to significantly larger
risk estimates.
So it seems to me that the earlier emissions and estimates
and ratings didn't take into account the H5N1-situation at all !?!
Nor do any of the pricing models apparantly consider virological expertise.
page 15
see here for an interesting survey on mortality bonds :
Milliman used an actuarial approach , while RMS used
an epidemiological approach , leading to significantly larger
risk estimates.
So it seems to me that the earlier emissions and estimates
and ratings didn't take into account the H5N1-situation at all !?!
Nor do any of the pricing models apparantly consider virological expertise.
Comment